Amarantus Bioscience Holdings Inc (AMBS)

[av1atic]

"We are currently establishing analytical performance, expect data towards the end of this quarter that will be released."

"We have some pilot clinical performance studies to characterize and confirm the literature which is in our hand and will be released in the 4th quarter"

"Will be initiating a pivotal CLIA registering study in the first half of 2014 with commercialization expected in the first half of next year"

"At that point, we should be, on our diagnostic side, commercial-stage, which is obviously a major value inflection. And the science of LymPro has been getting better and better over time"

3:00-3:55 in presentation



Keep trolling